Skip to main content
. 2016 Aug 22;7(49):80493–80507. doi: 10.18632/oncotarget.11492

Table 3. Results of multivariable Cox regression analysis in the entire cohort.

Prognostic Factor Hazard ratio 95% CI P
OS
Sex (Male vs. Female) 1.566 1.126-2.179 0.008
Differentiation (Poor vs. Moderate vs. Well) 1.055 0.838-1.328 0.647
pT status (T3 vs. T2 vs. T1) 1.345 1.023-1.769 0.034
pN status (N3 vs. N2 vs. N1 vs.N0) 2.014 1.733-2.341 < 0.001
Surgery (Qualified vs. Unqualified) 0.539 0.404-0.720 < 0.001
KIF-2C (<2.0 vs. ≥2.0) 1.259 0.959-1.654 0.097
DFS
Sex (Male vs. Female) 1.444 1.055-1.978 0.022
Differentiation (Poor vs. Moderate vs. Well) 1.108 0.885-1.387 0.369
pT status (T3 vs. T2 vs. T1) 1.307 1.006-1.698 0.045
pN status (N3 vs. N2 vs. N1 vs.N0) 1.984 1.711-2.300 < 0.001
Surgery (Qualified vs. Unqualified) 0.608 0.460-0.803 < 0.001
KIF-2C (<2.0 vs. ≥2.0) 1.213 0.931-1.579 0.152

CI: Confidence interval; pT, Pathologic tumor; pN, Pathologic node; OS, Overall survival; DFS, Disease-free survival; Qualified surgery, R0 resection with at least 12 resected lymph nodes; Unqualified surgery, R0 resection with less than 12 resected lymph nodes.